BLUEROCK THERAPEUTICS
BlueRock Therapeutics is a biotech company that plans to develop induced pluripotent stem cell (iPSC) therapies to cure a range of diseases using an industry-leading platform. One of the initial programs is to regenerate heart muscle in patients who have had a heart attack (myocard infarction, MI) or are suffering from chronic heart failure, leading causes of morbidity and mortality worldwid.
BLUEROCK THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
2016-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.bluerocktx.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
225 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Inversago Pharma
Inversago Pharma is a specialized, preclinical-stage biotech company.
Regenative Labs
Regenative Labs is a biotechnology research firm that produces regenerative medicine products.
Rion
RION is a clinical-stage regenerative medicine company.
SanBio
SanBio is a regenerative medicine company.
Saphetor
Saphetor is a personalised medicine company.
SmartPharm Therapeutics
SmartPharm Therapeutics is a second-generation gene-encoded therapeutics company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Versant Ventures
Versant Ventures investment in Series A - BlueRock Therapeutics
Bayer
Bayer investment in Series A - BlueRock Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-07-26 | BlueRock Therapeutics Announces New Board Chair, New President and CEO |
| 2020-03-04 | BlueRock Hires Former Unum Exec Ettenberg as Chief Scientific Officer |
Official Site Inspections
http://www.bluerocktx.com Semrush global rank: 4.41 M Semrush visits lastest month: 2.53 K
- Host name: acd92bd2ba22672fa.awsglobalaccelerator.com
- IP address: 99.83.192.58
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "BlueRock Therapeutics"
About - BlueRock Therapeutics LP
BlueRock is a wholly-owned, independently operated subsidiary of Bayer AG as a cornerstone of its Cell & Gene Therapy Platform. Learn about BlueRock's mission, leadership, & insights. See the science of cell and gene therapy and …See details»
Leadership - BlueRock Therapeutics LP
Stefan Irion, M.D., leads the Research organization at BlueRock Therapeutics. Since joining BlueRock in 2017, Stefan has taken on a number of roles in support of BlueRock’s scientific …See details»
BlueRock Therapeutics - Crunchbase Company Profile …
BlueRock Therapeutics is a biotech company that plans to develop induced pluripotent stem cell (iPSC) therapies to cure a range of diseases using an industry-leading platform.See details»
BlueRock Therapeutics - LinkedIn
BlueRock Therapeutics is a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. BlueRock Therapeutics’ cell+gene platform harnesses the power of cells to create new …See details»
BlueRock Therapeutics | LinkedIn
BlueRock Therapeutics is a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. BlueRock Therapeutics’ cell+gene platform …See details»
BlueRock Therapeutics receives FDA Regenerative Medicine …
May 30, 2024 Managed by the FDA’s Center for Biologics, Evaluation and Research (CBER), the RMAT program is dedicated to investigational regenerative medicines, including cell …See details»
BlueRock Therapeutics’ investigational cell therapy
Sep 27, 2024 Email: [email protected] . Contact for media inquiries Bayer: Silke Lengemann, phone +49 (173) 8990997 Email: [email protected] . Contact for media inquiries Bayer U.S.: Elaine …See details»
BlueRock Therapeutics - Craft
BlueRock Therapeutics is an engineered cell therapy company that develops regenerative medicines for intractable diseases. BlueRock's CELL+GENE platform is used to direct cellular …See details»
Bayer acquires BlueRock Therapeutics to build leading position in …
“We are extremely excited to be part of the world-class Bayer organization,” said Emile Nuwaysir, Ph.D., Chief Executive Officer, BlueRock Therapeutics. “We have built a premier cell therapy …See details»
BlueRock Therapeutics Announces New Board Chair, …
Jul 26, 2021 For more information, visit bluerocktx.com. About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition.See details»
Bayer acquires BlueRock Therapeutics to build leading position in …
Aug 8, 2019 "We are extremely excited to be part of the world-class Bayer organization," said Emile Nuwaysir, Ph.D., Chief Executive Officer, BlueRock Therapeutics. "We have built a …See details»
Mission & Values - BlueRock Therapeutics LP
Our mission is to discover and develop cell therapies that can change the way we treat disease and improve the lives of patients. Working at the frontier of science, our culture is rooted in our …See details»
BlueRock Therapeutics receives FDA Regenerative Medicine …
May 30, 2024 Email: [email protected] . Bayer Media Contact: Dr. Nuria Aiguabella Font, phone +49 1732329691 Email: [email protected] . Bayer U.S. Media …See details»
BlueRock Therapeutics phase I clinical trial for Parkinson’s disease ...
Mar 6, 2024 •Investigational cell therapy bemdaneprocel continues to be well tolerated with no major safety issues in all 12 participants in low and high dose cohorts through 18 months …See details»
Bayer acquires BlueRock Therapeutics to build leading position in …
Aug 8, 2019 "We are extremely excited to be part of the world-class Bayer organization," said Emile Nuwaysir, Ph.D., Chief Executive Officer, BlueRock Therapeutics. "We have built a …See details»
BlueRock Therapeutics Appoints Seth Ettenberg, Ph.D. Chief …
BlueRock Therapeutics, a wholly owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company with a mission to develop regenerative medicines for …See details»
BlueRock Therapeutics phase I clinical trial for Parkinson’s ... - Bayer
Mar 6, 2024 Berlin, Germany and Cambridge, MA USA, March 6, 2024 – Bayer AG and BlueRock Therapeutics LP, a clinical stage cell therapy company and wholly owned …See details»
FDA Recognizes BlueRock’s Parkinson Disease Cell Therapy
Jun 17, 2024 The FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation to BlueRockTherapeutics’s bemdaneprocel cell therapy for the potential treatment …See details»
Programs - BlueRock Therapeutics LP
Parkinson’s disease is a progressive neurodegenerative disorder caused by the loss of dopamine-producing cells in the brain. As the world’s second-most common neurodegenerative disorder, …See details»